Market Place
Reply
1. Diclofenac (25 mg) Soft Gel Capsules. The required quantity is 46,900 units in 2025, 93,950 units in 2026, 128,100 units in 2027, 170,000 units in 2028 & 190,000 units in 2029.
2. Diclofenac (20 mg/ g in 100 g) Gels. The required quantity is 18,800 units in 2025, 37,580 units in 2026, 52,200 units in 2027, 69,600 units in 2028 & 76,550 units in 2029.
3. Diclofenac (50 mg) Tablets. The required quantity is 222,800 units in 2025, 297,100 units in 2026, 371,350 units in 2027, 445,650 units in 2028 & 445,650 units in 2029.
4. Diclofenac (50 mg) Granules in Sachet. The required quantity is 202,250 units in 2025, 269,650 units in 2026, 337,100 units in 2027, 404,500 units in 2028 & 404,500 units in 2029.
5. Diclofenac (75 mg) Retard Film coated Tablets. The required quantity is 39,550 units in 2025, 52,730 units in 2026, 65,900 units in 2027, 79,100 units in 2028 & 2029 respectively.
Comments :
info@indeximinternational.com
INDEXIM INTERNATIONAL, one of the leading manufacturer, suppliers, exporter and importer of API, Pharmaceutical formulation, Novel molecule, APIs, Vet.-APIs, reference standard, Impurities, Excipients, Intermediates, Solvents, Vitamins, Nutraceuticals and Dietary supplements, silica gel, Regulatory documents service etc.
We are exporting several of our products to Latin American countries, Gulf & Asian, Ukraine, Russia, and also a few products to Australia, UK & USA.
We are also contract manufacturer of APIs and attached is the list of products and by cooperation with other manufacturers in India. Also, most of the products are from WHO cGMP, ISO, GMP manufacturers.
sales.indeximinternational@gmail.com
info@indeximinternational.com
www.indexim.in
GSTN-24AADFI5767R1ZO
IEC -CODE : 0811024407
FDA No- 20B-168327/21B-168328
ISO 9000 AND GMP APPROVED
hostrinlifesciences@gmail.com
Dear Friend,
Greetings from Hostrin Life Sciences!!!
Hostrin offers the following services:
1.We do support Tech transfer and Dossiers for Pharmaceutical, Biopharmaceutical, Nutraceutical, Biotech and Biosimilars in CTD, eCTD, ACTD, ANDA formats. DMF support for API's as well.
Tech transfer support and Registration of Dossiers in MOH /MHRA/EMEA/FDA with 5 modules including BA and BE studies /Clinical studies/trials for finished formulation's in Pharmaceutical, ayurveda, Biotech, Biosimilar, vitamins , Peptides and Transdermal patches too.
2. eCTD publishing with potential softwares like Lorenz/Docubridge/PharmaReady/E-Way addressing post submission queries from all regulatory authorities.
3. Support for Impurity's, Reference standards and RLD's
4. Services for IPR & Regulatory compliance with all risk assessments.
5. Services for Quality Management Systems: GXP/GMP Advisory & EU-GMP/UK-MHRA/TGA/PMDA/WHO-GMP/PICS and USFDA_21_CFR with all GAP filling Audits.
6.Supporting for QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars manufacturers to save the time and cost effective technology.
7. Custom synthesis, contract manufacturing services and conducting BE studies and clinical studies from US-FDA,EU-GMP, UK-MHRA, TGA-Australia approved CRO's/BE Study Centers.
8. Synthetic Resin technologies support.
9. Cleaning validation/ toxicology studies reports (PDE/ADE I OEL) values for commercial manufacturing of APIs and finished formulations.
10. Pharmacovigilance services.
Pls don't hesitate to send your inquiries. For your reference, please go through our website www.hostringlobal.com
For all supply related queries like API, Intermediates, Finished Formulations please visit our website www.cristoneglobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343
www.hostringlobal.com
